US › Healthcare

Precipio Inc (PRPO)

US · Healthcare · Diagnostics & Research

$26.44-0.83%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.0M

Revenue YoY

+24.2%

Net profit

$-219,000

Profit YoY

-395.9%

EPS

$-0.12

Net margin

-3.1%

Key statistics

Market cap

$48.9M

Forward P/E

15.4

P/B

3.39

Book value

$8.25

EPS (TTM)

$-0.62

52-week high

$33.63

52-week low

$16.00

50-day MA

$25.23

200-day MA

$25.16

Beta

1.33

Analyst view

Analysts rate Precipio Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $19.00.

Shareholding

Insiders

12.63%

Institutions

17.71%

Largest institutional holders

Fund	Stake
BlackRock Inc	1.62%
Vanguard Capital Management, LLC	1.42%
Renaissance Technologies Corp	1.08%
Geode Capital Management, LLC	1.05%
Citadel Advisors Llc	0.82%
Vanguard Fiduciary Trust Co	0.52%
Dimensional Fund Advisors, Inc.	0.47%
UBS Group AG	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Precipio Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.